311 related articles for article (PubMed ID: 24648731)
41. Anti-HER2 IgY antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast cancer cells.
Xiao Y; Gao X; Taratula O; Treado S; Urbas A; Holbrook RD; Cavicchi RE; Avedisian CT; Mitra S; Savla R; Wagner PD; Srivastava S; He H
BMC Cancer; 2009 Oct; 9():351. PubMed ID: 19799784
[TBL] [Abstract][Full Text] [Related]
42. Affibody-DyLight conjugates for in vivo assessment of HER2 expression by near-infrared optical imaging.
Zielinski R; Hassan M; Lyakhov I; Needle D; Chernomordik V; Garcia-Glaessner A; Ardeshirpour Y; Capala J; Gandjbakhche A
PLoS One; 2012; 7(7):e41016. PubMed ID: 22911732
[TBL] [Abstract][Full Text] [Related]
43. Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas.
Okarvi SM; AlJammaz I
Molecules; 2019 Aug; 24(17):. PubMed ID: 31470531
[TBL] [Abstract][Full Text] [Related]
44. Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors.
Hathaway HJ; Butler KS; Adolphi NL; Lovato DM; Belfon R; Fegan D; Monson TC; Trujillo JE; Tessier TE; Bryant HC; Huber DL; Larson RS; Flynn ER
Breast Cancer Res; 2011 Nov; 13(5):R108. PubMed ID: 22035507
[TBL] [Abstract][Full Text] [Related]
45. Intraoperative imaging of metastatic lymph nodes using a fluorophore-conjugated antibody in a HER2/neu-expressing orthotopic breast cancer mouse model.
Wu J; Ma R; Cao H; Wang Z; Jing C; Sun Y; Zhang Y; Yang Z; Hoffman RM; Tang J
Anticancer Res; 2013 Feb; 33(2):419-24. PubMed ID: 23393332
[TBL] [Abstract][Full Text] [Related]
46. In vivo fluorescence lifetime imaging monitors binding of specific probes to cancer biomarkers.
Ardeshirpour Y; Chernomordik V; Zielinski R; Capala J; Griffiths G; Vasalatiy O; Smirnov AV; Knutson JR; Lyakhov I; Achilefu S; Gandjbakhche A; Hassan M
PLoS One; 2012; 7(2):e31881. PubMed ID: 22384092
[TBL] [Abstract][Full Text] [Related]
47. Characterization and cancer cell targeted imaging properties of human antivascular endothelial growth factor monoclonal antibody conjugated CdTe/ZnS quantum dots.
Pang L; Xu J; Shu C; Guo J; Ma X; Liu Y; Zhong W
Luminescence; 2014 Dec; 29(8):1177-82. PubMed ID: 24833027
[TBL] [Abstract][Full Text] [Related]
48. Comparison of HER2-Targeted Antibodies for Fluorescence-Guided Surgery in Breast Cancer.
AghaAmiri S; Simien J; Thompson AM; Voss J; Ghosh SC; Hernandez Vargas S; Kim S; Azhdarinia A; Tran Cao HS
Mol Imaging; 2021; 2021():5540569. PubMed ID: 34194285
[TBL] [Abstract][Full Text] [Related]
49. Quantitative diagnosis of HER2 protein expressing breast cancer by single-particle quantum dot imaging.
Miyashita M; Gonda K; Tada H; Watanabe M; Kitamura N; Kamei T; Sasano H; Ishida T; Ohuchi N
Cancer Med; 2016 Oct; 5(10):2813-2824. PubMed ID: 27666577
[TBL] [Abstract][Full Text] [Related]
50. Fluorescent immunolabeling of cancer cells by quantum dots and antibody scFv fragment.
Zdobnova TA; Dorofeev SG; Tananaev PN; Vasiliev RB; Balandin TG; Edelweiss EF; Stremovskiy OA; Balalaeva IV; Turchin IV; Lebedenko EN; Zlomanov VP; Deyev SM
J Biomed Opt; 2009; 14(2):021004. PubMed ID: 19405717
[TBL] [Abstract][Full Text] [Related]
51. [
Li X; Sun X; Lin H; Zhang P; Jiao M; Zhang N
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2024 Jun; 41(3):620-626. PubMed ID: 38932550
[TBL] [Abstract][Full Text] [Related]
52. Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field.
Yi X; Wang F; Qin W; Yang X; Yuan J
Int J Nanomedicine; 2014; 9():1347-65. PubMed ID: 24648733
[TBL] [Abstract][Full Text] [Related]
53. A DM1-doped porous gold nanoshell system for NIR accelerated redox-responsive release and triple modal imaging guided photothermal synergistic chemotherapy.
Xu P; Wang R; Yang W; Liu Y; He D; Ye Z; Chen D; Ding Y; Tu J; Shen Y
J Nanobiotechnology; 2021 Mar; 19(1):77. PubMed ID: 33741008
[TBL] [Abstract][Full Text] [Related]
54. Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference.
Tan WB; Jiang S; Zhang Y
Biomaterials; 2007 Mar; 28(8):1565-71. PubMed ID: 17161865
[TBL] [Abstract][Full Text] [Related]
55. Near-Infrared Photoimmunotherapy Using a Small Protein Mimetic for HER2-Overexpressing Breast Cancer.
Yamaguchi H; Pantarat N; Suzuki T; Evdokiou A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31757056
[TBL] [Abstract][Full Text] [Related]
56. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
[TBL] [Abstract][Full Text] [Related]
57. Immunomagnetic bead-based bioassay for the voltammetric analysis of the breast cancer biomarker HER2-ECD and tumour cells using quantum dots as detection labels.
Freitas M; Nouws HPA; Keating E; Fernandes VC; Delerue-Matos C
Mikrochim Acta; 2020 Feb; 187(3):184. PubMed ID: 32088788
[TBL] [Abstract][Full Text] [Related]
58. Multimodal image-guided folic acid targeted Ag-based quantum dots for the combination of selective methotrexate delivery and photothermal therapy.
Hashemkhani M; Muti A; Sennaroğlu A; Yagci Acar H
J Photochem Photobiol B; 2020 Dec; 213():112082. PubMed ID: 33221627
[TBL] [Abstract][Full Text] [Related]
59. Synthesis of NAC capped near infrared-emitting CdTeS alloyed quantum dots and application for in vivo early tumor imaging.
Xue B; Deng DW; Cao J; Liu F; Li X; Akers W; Achilefu S; Gu YQ
Dalton Trans; 2012 Apr; 41(16):4935-47. PubMed ID: 22451225
[TBL] [Abstract][Full Text] [Related]
60. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
